open federal funding opportunity
DoW Multiple Sclerosis Clinical Trial Award
Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26…
- Agency
- Defense Health Agency Contracting Activity - DHACA
- Opportunity number
- HT942526MSRPCTA